Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

The Pharmaceutical "Business with Disease"

Up to date news and comment about the "Business with Disease".

December 22, 2003
NHS to sue seven drug firms for 'fixing price' of penicillin
The UK 's National Health Service is planning to sue seven large drugs companies for £30m, for allegedly fixing the price of one of Britain 's most common antibiotics. Legal action is also planned against the companies for allegedly defrauding the NHS of £170m in relation to the prices of 30 other prescription drugs
Read article at Independent.co.uk

December 20, 2003
How big pharma talks up the benefits of its products to the regulators
During health technology appraisals the National Institute for Clinical Excellence (NICE) invites sponsors of the technology to make a submission in support of their product. These submissions can be of variable quality. We examine some of the more dubious techniques that can be used by sponsoring organisations to make their products seem attractive to those making reimbursement decisions.
Read article at Bmj.com

December 17, 2003
Go-ahead for EU drugs copyright
European Union boosts pharmaceutical industry yet again as Parliament votes through a plan to extend copyright on drug research to ten years
Read article at Eupolitix.com

December 7, 2003
Revealed: how drug firms 'hoodwink' medical journals
Hundreds of articles in medical journals claiming to be written by academics or doctors have been penned by ghost-writers in the pay of drug companies according to an investigation carried out by the UK 's Observer newspaper
Read article at The Observer

December 4, 2003
HRT no longer recommended for osteoporosis prevention
Hormone replacement therapy (HRT) is no longer recommended as first choice of therapy for prevention of osteoporosis, according to new advice from the UK 's Medicines and Healthcare products Regulatory Agency (MHRA) released yesterday. The statement follows a European-wide review of the balance of risks and benefits of HRT in response to growing concerns about the safety of HRT in long-term use
Read article at Nutraingredients.com

December 2, 2003
Medicare drug plan leaves kids holding bill
This bill is so wrongheaded that it's hard to know where to begin. Lobbied heavily by pharmaceutical companies, which make substantial contributions to political campaigns, the Republican leadership decided not to allow Medicare to use its buying power to negotiate lower prices with drug companies. That borders on insane virtually guaranteeing that prices for prescriptions drugs -- already high -- will soar into the stratosphere
Read article at Timesunion.com

November 29, 2003
Drug company pushes for all children under 2 to be vaccinated against pneumonia
The pharmaceutical company Wyeth has launched a campaign to persuade the UK government to extend the use of its children's pneumococcal vaccine to all children under the age of 2. Currently, the Department of Health recommends it s use only in children who are at risk because of chronic disease
Read article at BMJ.com

November 29, 2003
Drug companies succeed in keeping payments to doctors secret
Lobbying by Australia's drug industry association, Medicines Australia, has persuaded the Australian Competition and Consumer Commission (ACCC) to scrap a proposal to require public disclosure of drug companies' sponsorship of doctors' travel and accommodation and other promotional benefits
Read article at BMJ.com

November 27, 2003
Excess of vitamin C dangerous
Another attack on vitamin C a Chinese dermatologist says it causes leukoderma
Read article at Foodingridientsfirst.com

November 10, 2003
Former Zyklon-B maker goes bust
IG Farben the German company which produced the poison gas used in Nazi concentration camps during the Second World War is to file for bankruptcy
Read article at Independent Home

October 31, 2003
Australia to clamp down on natural medicines sector
An Australian government review of herbal and complementary medicines looks set to provoke a wave of extensive reforms to the sector, giving the national medicines body greater powers to regulate natural health products
Read article at Nutraingridients.com

October 20, 2003
Dangerous Combo Could Lead to Stroke
More bad news for HRT - postmenopausal women with high blood pressure might want to think twice before they try hormone therapy. The combination could put them at increased risk for stroke, says a Danish study
Read article at Independent Home

October 17, 2003
Drugs will soon offer HIV patients a normal lifespan
Pharma-cartel attempts to convert Aids into a chronic disease – a classic ‘business with disease’ strategy. Nearly all HIV patients receiving modern drug treatments can expect to live at least 10 years from the date of infection and may ultimately enjoy a normal lifespan, researchers said yesterday
Read article at Independent Home

October 16, 2003
Study: 'Bubble boy' gene therapy causes cancer
The dangers of gene therapies exposed. A gene therapy that corrected an inherited immune system disease in two French children also activated a cancer-causing gene in the youngsters, leading to leukaemia
Read article at Cnn.com

October 4, 2003
Head of German medicine body likens HRT to thalidomide
Professor Bruno Müller-Oerlinghausen, the head of Germany’s Commission on the Safety of Medicines, called HRT a "national and international tragedy." Comparing it to thalidomide, he said that the "naive and careless use of a medication that is perceived as natural and optimal" had caused many unnecessary deaths among women. The Commission also launched a fierce attack on the pharmaceutical industry, suggesting that it had turned a "natural phase of life," the menopause, into a hormonal sickness that needed treatment.
Read article at Bmj.com

September 20, 2003
German scientists withdraw research paper on cancer vaccine
More than three years after publishing a research paper in Nature Medicine, 15 German scientists retracted it because of “several incorrect statements and the erroneous presentation of primary data, results and conclusions”
Read article at Bmj.com

September 20, 2003
NICE is told to break its close links with drug industry
The UK 's National Institute for Clinical Excellence (NICE) has been advised by an independent review to break its close links with the drug industry and to make its processes more transparent. Experts from the World Health Organization who carried out the review have advised NICE that, to avoid any possible bias, pharmaceutical physicians should not be members of committees that make judgments on particular drugs or devices
Read article at Bmj.com

August 28, 2003
Zoloft Found Safe, Effective in Children
A trial funded by Pfizer (the makers of Zoloft) finds that the drug appears to be safe and effective for children and adolescents suffering from major depressive disorder [would the results have been released if it had shown otherwise?
Read article at Healthday.com

August 19, 2003
Possible Conflict of Interest Within Medical Profession
Nearly half of medical school faculty members who serve on Institutional Review Boards (IRBs) also serve as consultants to the pharmaceutical industry -- a situation that can cause potential conflicts of interest
Read article at Healthday.com

August 15, 2003
Glaxo adds warnings to asthma drugs after deaths in study
GlaxoSmithKline P.L.C., the world's top seller of respiratory drugs, has added warnings to its Advair and Serevent asthma treatments after some patients died in a study
Read article at Philly.com

August 14, 2003
Merck under investigation by US Justice Department for its marketing and sales tactics
Merck & Co., the second-biggest U.S. drugmaker, says it has received a federal subpoena for documents related to the company's marketing and sales activities.
Read article at Philly.com

August 13, 2003
Suit alleges promotions of drug skirted U.S. law
A lawsuit in the U.S. District Court in Boston alleges that Neurontin's manufacturer, Parke-Davis, and its parent, Warner Lambert, which merged with Pfizer Inc. two years ago, flouted federal law in the 1990s with an illegal marketing plan intended to drive up Neurontin's sales. Pfizer has disputed the allegations
Read article at Philly.com

August 9, 2003
Not a magic medicine
Comment piece on HRT study: Not a magic medicine. The new HRT study will empower women by giving us facts we need
Read article at Guardian.co.uk

August 8, 2003
Revealed: HRT causes breast cancer in 2,000 women a year
Not only does HRT nearly double a woman’s risk of heart attack it also makes breast cancer twice as likely
Read article at The Independent`s

August 4, 2003
Drug ads spike consumer demand
With the world's biggest pharmaceutical companies vying for a bigger share of the drug market, television advertisements of prescription drugs have had a direct impact on consumers, medical professionals, businesses and health insurers
Read article at The Detroit News

August 4, 2003
South African Health Minister Manto: Aids drugs not like popping aspirin
Heckling and raucous shouts of "Aids treatment now" and "Shame on you" greeted the minister of health at the first South African Aids Conference. More than 600 delegates attended the opening at the International Conference Centre in Durban on Sunday night.
Read article at Iol.co.za

July 31, 2003
Osteoporosis Drug Linked to Bone Disease
Novartis osteoporosis drug Aredia linked to bone disease
Read article at Medical Breakthroughs

July 28, 2003
Will cancer ever be cured? Recent results leave many in doubt.
Dr. Andrew von Eschenbach, head of the National Cancer Institute, argues that a cure is not even necessary — converting cancer into a chronic disease, like diabetes or AIDS is enough. When the head of the National Cancer Institute comes out and openly declares that a cure for cancer is not necessary and that the goal is to turn cancer into ‘a chronic disease’ only one interest group will benefit – the pharma-cartel.
Read article at USA Today

July 14, 2003
Statins Strike Out Against Osteoporosis
Cholesterol-lowering statin drugs don't build stronger bones for older women or reduce their risk of fractures, a new study shows
Read article at Healthday.com

July 4, 2003
West Virginia Supreme Court of Appeals Reverses Order Denying Class Certification to Rezulin Plaintiffs
The West Virginia Supreme Court of Appeals reversed, on Thursday, a lower court's November 2001 order denying class certification of a proposed class-action involving Rezulin, the prescription diabetes drug supplied by the Warner-Lambert Company before Pfizer Inc acquired Warner-Lambert in June 2000.
Read article at Today`s News

July 4, 2003
Commission calls for stronger scientific base for EU pharmaceutical industry
G10 High Level Medicines Group calls for changes to strengthen the competitiveness of the European pharmaceutical industry
Read article at Cordis News

July 1, 2003
Pharmaceutical industry holds out on its position over TRIPS
The U.S. drug industry is recasting its position on a global trade agreement that would give poor countries access to generic drugs while protecting company investments in name-brand pharmaceuticals.
Read article at washingtontimes.com

July 1, 2003
Peers push for vitamin curbs rethink
Members of the UK House of Lords voted by a majority of 53 last night to call upon ministers to revoke regulations due to implement the EU's Food Supplements Directive in August 2005. But Health Minister Lord Warner said the vote would make no difference, as the UK was obliged to implement the directive
Read article at News.telegraph.co.uk

June 29, 2003
Tricks of the trade
Taking a lead from the BMJ issue criticising the relationship between the pharmaceutical industry and GPs, The Observer newspaper asks: “Extravagant freebies, insider 'experts' and biased research... Should we be concerned about the way the pharmaceutical industry woos our GPs?”
Read article at The Observer

June 23, 2003
Vitamins "may contribute to cardiovascular death"
In a further unfounded attack on natural health US researchers say that antioxidant vitamins are not effective at reducing the risk of cardiovascular disease and may even contribute to an increase in cardiovascular death.
Read article at Discovery Health

June 21, 2003
BMJ-readers want transparency in link between doctors and drug firms
After their attack on big pharma a reader’s poll in the BMJ shows that 96% of those voting would like to see all financial ties between doctors and drug companies conducted with transparent contracts that are disclosed to patients.
Read article at Bmj.com

June 7, 2003
Latest HRT trial results show risk of dementia
New study shows that postmenopausal women who take combined HRT face twice the risk of dementia
Read article at Bmj.com

June 2, 2003
Experimental drug 2C4 has shown a ‘remarkable’ effect in patients with several different types of cancers
A new wonder drug has been developed that can attack several different types of cancers. Early trial results have shown a "remarkable" effect in patients with advanced breast, prostate, lung, ovarian, colon, pancreas and connective tissue cancers, say scientists.
Read article at Sky News

May 31, 2003
BMJ Savages Big Pharma
In startling further evidence of the empowerment provided by this Foundation’s information campaigns, the British Medical Journal has launched an all-out attack on big pharma and the medical establishment. Copies of all the relevant articles can be accessed using the links below:

May 29, 2003
More bad news for GlaxoSmithKline’s Seroxat and other SSRI drugs
Health professionals in the UK have raised concerns about possible links between the anti-depressant drug Seroxat and eight cases of suicide over the past three years, the Department of Health said.
Read article at Femail.co.uk

May 24, 2003
Novartis accused of breaching advertising regulations in adverts for its drug Elidel
The Drug and Therapeutics Bulletin has accused the drug company Novartis of breaching advertising regulations in its advertisement for pimecrolimus, a new cream for treating dermatitis.
Read article at Bmj.com

May 23, 2003
Bill to Boost Industry Fees That Fund FDA
With little public discussion and limited debate on Capitol Hill, the US Congress is moving to substantially expand the program through which companies pay large fees to the Food and Drug Administration to review their new drug applications -- making the agency increasingly dependent on the businesses that it regulates
Read article at Washingtonpost.com

May 22, 2003
FDA has been lax in controlling follow-up drug studies – half of required Phase 4 trials have yet to be carried out
More than half of the product research that drug companies routinely promise as a condition of sales approval has yet to begin, the Food and Drug Administration said Thursday.
Read article at Abcnews.com

May 22, 2003
Cancer risk 45% higher for women taking second generation contraceptive pill for three years of more
Contraceptive pills taken by more than three million women in Britain may be significantly raising their risk of breast cancer, it was claimed last night. A 45 per cent increase in the disease was found among women who had been taking the secondgeneration Pill for three years or more.
Read article at Femail.co.uk

May 8, 2003
Watchdog warning on vitamin pills
Taking high doses of some vitamin and mineral supplements can be harmful, Britain's food watchdog warned on Thursday.
Read article at Cnn.com

May 8, 2003
Bioterror Measures Aim to Keep Food Safe
FDA to control food supplies in US in the event of a terrorist attack under rules contained in the Public Health Security and Bioterrorism Preparedness and Response Act 2002
Read article at Healthscoutnews.com

May 7, 2003
Warning over vitamin doses
People who take large doses of certain vitamins and minerals risk permanently damaging their health, a government watchdog has warned.
Read article at BBC News

May 7, 2003
Professors tell of New Zealand's wasted millions on diet supplements
University professors in New Zealand say people are wasting money on dietary supplements – "There's probably billions of dollars being wasted worldwide on things that are doing no good."
Read article at The New Zealand Herald

May 6, 2003
Pharma-Cartel Runs Amok
The Global Deception Campaign Denying The Health Benefits Of Vitamins Can No Longer Prevent The Collapse Of The Pharmaceutical House Of Cards!

May 1, 2003
Side Effect Tarnishes Blood Cancer Drug's Luster
The once notorious drug thalidomide may help against blood cancer – but also causes dementia
Read article at Healthscoutnews.com

April 27, 2003
Dying for Drugs
Empowered by Dr Rath’s consistent exposure of the pharmaceutical “business with disease” Europe’s leading news magazine “Der Spiegel” was able to openly and fearlessly criticise this industry without fear of threat of a legal backlash - and now a mainstream television station in the UK has taken up the torch.

April 24, 2003
Is Big Pharma the next target for attack?
The state of Connecticut says its neediest citizens have been scammed by drug companies. Big Tobacco, Big Banking—and now Big Pharma? It seems fanciful to speculate during a week in which Pfizer reported profits, for its latest quarter, of $4.7 billion, that America's mighty pharmaceuticals giants might find themselves vulnerable to the political attacks that have tormented some of America's other large industries.
Read article at Economist.com

April 23, 2003
Burkina Faso to import cheaper generic Aids drugs from India
Burkina Faso is to import cheaper generic drugs from India for people living with HIV under an agreement with the Chemical Industrial Pharmaceutical Laboratories (CIPLA) of India, Minister of Health Alain Yoda said on Tuesday in Ouagadougou.
Read article at Mail and Guardian Online

April 23, 2003
Statins May Cut Alzheimer's Risk
They significantly lower brain cholesterol levels

Statins now being touted as a treatment for Alzheimer’s
Read article at Healthscoutnews.com

April 22, 2003
JAMA condemns pharmaceutical industry over halted blood pressure drug study
In a scathing condemnation of the pharmaceutical industry, editors at one of the nation's top medical journals said a company shortchanged science by halting a large study of high blood pressure drugs to save money.
Read article at abcnews.com

April 15, 2003
New call for cheap Aids drugs
The largest pension fund in the US gives GSK three months to come up with a cheap Aids drug plan – with the implied threat that if it doesn’t, the fund will sell off its $760 million stockholding
Read article at BBC News

April 15, 2003
Prozac sales are in trouble due to side effects. So what do pharma do? Find a new use for Prozac of course!
The anti-depressant drug Prozac could help doctors tackle cancer, says a UK-based research team.
Read article at BBC News

April 9, 2003
After the Chemo -- Do You Remember?
Pharmaceutical industry develops new disease - Chemobrain - memory loss following chemotherapy. Of course, they have a treatment for it....
Read article at Healthscoutnews.com

April 8, 2003
HRT patches tackle prostate cancer
After reports that HRT is 'clinically useless' for menopausal symptoms, the pharmaceutical industry are now building a new market for these drugs - treating prostate cancer
Read article at BBC News

March 29, 2003
Increased drug spending is creating funding crisis, report says
UK Health Service spent 5.5 billion pounds buying primary care prescription drugs in 2002 - including upping spending on statins by 33% from 2001 levels
Read article at Bmj.com

March 29, 2003

US wants Australia to modify its cheap drugs scheme as part of trade deal
US government pressures Australia to modify its cheap drugs scheme on behalf of PhRMA (US drug industry trade organisation). Martyn Goddard, senior policy officer with the Australian Consumers' Association says, "Other countries look to the scheme as a model of how to control the high cost of new medicines, and the big companies don't like that."
Read article at Bmj.com

March 26, 2003
Vaccine link to heart disease under review
US Centers for Disease Control investigate link between their smallpox vaccination program and heart attacks - 7 people so far have had heart attacks after being vaccinated, one fatal and one still on life-support
Read article at Mercurynews.com

March 25, 2003

Heart Drug Carries Dangers

40 year old heart drug linked to increased risk of death in new US study
Read article at healthscoutnews.com

March 24, 2003

Drug argument embroils psychiatrists, pharm cos.

A "psycho-pharmaceutical" industry has slowly undermined the therapeutic foundations of psychiatry with a drug- and profit-driven model for treatment of illnesses - and invented some along the way
Read article at cnn.com

March 22, 2003
Lawyers may seek judicial review of panel reviewing paroxetine

Lawyers call for judicial review after it is found that the Committee on Safety of Medicines panel set up to review the case against Seroxat maker GlaxoSmithKkine includes several GSK shareholders
Read article at Bmj.com

March 15, 2003

FDA officials argue over safety of new arthritis drug

An external advisory panel to the US Food and Drug Administration last week rejected calls from FDA safety experts to withdraw a drug for rheumatoid arthritis from the market. The Arthritis Advisory Committee found that the benefits of the Aventis drug leflunomide (Arava) outweighed its rare side effects, despite an internal FDA report that said that one in 200 users may be at risk of serious acute liver injury.
Read article at Bmj.com

March 13, 2003

UK Coroner calls for inquiry into Seroxat

Seroxat, the world's biggest-selling antidepressant, should be withdrawn while its safety is fully investigated, advises a coroner who recorded an open verdict on a man who killed himself within a fortnight of starting a course of the drug.
Read article at The Guardian

March 6, 2003
GlaxoSmithKline under fresh attack in the United States
Drugs group GlaxoSmithKline is facing a growing consumer boycott in the US, at the same time as it is fighting in court to protect its patents from cheaper generic alternatives.
Read article at Thisismoney.com

March 3, 2003
The pharmaceutical industry promotes statin drugs yet again, repeating the same old propaganda
Thousands of lives are being saved every year because doctors are prescribing more cholesterol-lowering drugs, government figures are expected to show.
Read article at BBC News

March 3, 2003
Bayer executive's testimony in court confirms the company was well aware of the dangers of Baycol
A senior executive at Bayer AG has testified in court that other company executives in the United States recommended against selling the anti-cholesterol drug Baycol several years before it was introduced in 1997 because they thought its sales potential was limited.
Read article at International Herald Tribune

March 2, 2003
Pharmaceutical company boss suffering from cancer exposes the unethical practices that are rife in clinical trials of drugs run by pharmaceutical companies
For the past 40 years Professor David Horrobin has been developing new medicines. In 1977 he founded Scotia Holdings, which was once one of Scotland's most promising biotechnology firms. But today, as the drug company boss is dying of cancer, he has decided to expose the unethical experiments that his industry carries out on patients.
Read article at sundyherald.com

February 24, 2003
Three workers sue GSK claiming exposure to pill ingredients damaged their health
Three women who used to work for GlaxoSmithKline plan to sue Europe's biggest drugmaker, claiming their health was damaged by exposure to ingredients while packing pills at one of its British factories.
Read article at Yahoo.com

February 24, 2003
US Trials of an experimental Aids vaccine show mixed results
The world's first Aids vaccine to undergo mass trials on humans has yielded disappointing results, failing to protect most of the volunteers against HIV infection, its makers announced today.
Read article at Sundaytimes.co.za

February 24, 2003
GlaxoSmithKline's Serevent is killing asthmatics - UK government to investigate
The government is to investigate an asthma drug which has been linked with fatalities. However, experts stress that there is no evidence to suggest the drug is unsafe and have urged asthmatics to continue with their medication.
Read article at BBC News

February 23, 2003
More than half the members of the Scottish Medicines Consortium
have financial interests in the pharmaceutical industry - no worse than similar English and Welsch bodies

It was set up to end 'postcode prescribing' by advising health boards across Scotland which new medicines should be available on the NHS and ensuring equality of treatment. But just one year after the Scottish Medicines Consortium was established by the Scottish Executive, its ability to decide how public money should be spent is in doubt as more than half its members reveal they have financial interests in the pharmaceutical industry.
Read article at sundyherald.com

February 22, 2003
Documents that prove Bayer knew of the dangers of Baycol years before
the drug was finally withdrawn have been released by prosecutors in the USA
Executives at Bayer AG knew of problems with the company's anti-cholesterol drug Baycol years before it was pulled from the market, according to newly disclosed company documents, The New York Times reported on Saturday.
Read article at abcnews.com

February 21, 2003
Big Pharma target women in drive to expand markets
Women are becoming the most attractive target audience for healthcare companies, claims a new report from market analysts Datamonitor. A combination of increasing Internet access, a general interest in health issues among women along with high levels of interaction with doctors are all driving the trend.
Read article at Nutraingredients.com

February 14, 2003
Ibuprofen dangerous for heart attack patients
Fresh evidence adds to suspicions that ibuprofen could be dangerous for most heart patients because it can block the blood-thinning benefits of aspirin.
Read article at cnn.com

February 14, 2003
Common painkiller drug is deadly in large doses
As cold and flu season sends Canadians to their drug stores in search of relief, Health Canada has issued a new warning that the acetaminophen in many over-the-counter medications is deadly in large doses.
Read article at The Globe And Mail

February 13, 2003
New York State v GlaxoSmithKline

On February 13th 2003, exactly eleven days after the publication of Dr Rath's first Open Letter exposing the financial interests behind the pharmaceutical 'business with disease' New York State Attorney General Eliot Spitzer filed a complaint in the Supreme Court of the State of New York against GlaxoSmithKline (GSK) for making fraudulent and deceptive misrepresentations that conceal the true average wholesale price of its drugs from consumers, Government agencies and drug price reporting services.

February 11, 2003
AstraZeneca applies for European license for Iressa -
deaths in Japan appear to be ignored

AstraZeneca PLC said it has submitted a Marketing Authorisation Application for Iressa in Europe, for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients previously treated with platinum-based and docetaxel chemotherapy.
Read article at III.co.uk

February 9, 2003
Patients used as drug guinea pigs by UK doctors
as pharma companies pay out millions to test drugs

When Italia Sudano went for a check-up with her GP, Dr Robert Adams, she was in good health. Her husband had died a few months earlier and her blood pressure was a little high.
Read article at The Observer

February 9, 2003
Pharma drugs found in the drinking water of 4 Canadian cities
It's already known that medications that pass through the human body can get flushed into the sewer system and find their way into lakes and streams. In most cases, sewage treatment plants filter the drug residue out. But some gets through and poses a threat to fish and wildlife. What we didn't know until now was whether drugs were finding their way into our drinking water and creating a direct threat to human health.
Read article at CTV.ca

February 7, 2003
Recently published study supports use of
more pharma drugs in European health systems

According to a recently published study, the development and better application of innovative medicines are both essential to improving health care systems throughout Europe.
Read article at Cordis.lu

February 7, 2003
Research indicates that mixing pharma drugs is potentially fatal -
antibiotics and Prozac for example can cause severe heart problems

Millions of Americans, especially women, could be putting themselves at risk by taking combinations of common medications with potentially deadly side effects.
Read article at HealthScoutNews.com